Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kuliczkowski

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Medical Oncology (Northwood, London, England)|January 10, 2002
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter studyJ Walewski, E Kraszewska, O Mioduszewska, et al.
British Journal of Haematology|February 26, 2000
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patientsT Robak, J Z Bloński, M Kasznicki, et al.
Leukemia|March 5, 2004
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III studyJ Holowiecki, S Grosicki, T Robak, et al.
Bone Marrow Transplantation|July 10, 2002
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research GroupJ Czyz, A Hellmann, R Dziadziuszko, et al.
Leukemia Research|December 3, 2015
Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma GroupL Usnarska-Zubkiewicz, J Dębski, A Butrym, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Medical Oncology (Northwood, London, England)|January 10, 2002
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter studyJ Walewski, E Kraszewska, O Mioduszewska, et al.
British Journal of Haematology|February 26, 2000
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patientsT Robak, J Z Bloński, M Kasznicki, et al.
Leukemia|March 5, 2004
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III studyJ Holowiecki, S Grosicki, T Robak, et al.
Bone Marrow Transplantation|July 10, 2002
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research GroupJ Czyz, A Hellmann, R Dziadziuszko, et al.
Leukemia Research|December 3, 2015
Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma GroupL Usnarska-Zubkiewicz, J Dębski, A Butrym, et al.
Pageof 10